Wusheng Lu

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0003-0100-3804

发表论文 65 篇 · 总被引 664 次 · h-index 14

代表论文

• Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization (2017 · Medicine · 被引 58)
• Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria (2015 · European Journal of Gastroenterology & Hepatology · 被引 56)
• Neutrophil-lymphocyte Ratio Plus Prognostic Nutritional Index Predicts the Outcomes of Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization (2017 · Scientific Reports · 被引 31)
• Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria (2016 · Journal of Surgical Research · 被引 22)
• Update meta-analysis of the CYP2E1 Rsa I /Pst I and Dra I polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies (2016 · Journal of Clinical Pharmacy and Therapeutics · 被引 21)
• Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson’s Disease by Downregulating Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1) (2020 · Medical Science Monitor · 被引 19)